A peek behind the startup veil

Public companies have to disclose to their stockholders the minutiae of each expenditure, of each home run and each shuddering failure. Private companies, on the other hand, can rake in millions of venture dollars — and stay absolutely mum about what they actually do with it.

STAT’s Kate Sheridan takes a peek behind the private company veil, analyzing the performance of four biotech startups — Vor Biopharma, Tiburio Therapeutics, Apic Bio, and Ribon Therapeutics. 

Are these stealthy startups doing what they said they’d do with their funding? And how are they doing, overall? 

Read more.